AMD Ryan Initiative Study (ARIS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03092492|
Recruitment Status : Recruiting
First Posted : March 28, 2017
Last Update Posted : April 17, 2018
To learn more about AMD.
People ages 55 and older with any of the following:
AMD or changes in the retina that put them at risk for AMD
Participants will be screened with:
Eye exam: The pupil will be dilated with eye drops. Eye pressure and movements will be checked. Pictures will be taken of the inside of the eye.
Reading an eye chart.
Optical coherence tomography (OCT): The eyes are dilated. A machine measures the thickness of the retina.
Participants will have a first visit that includes:
Repeat of screening procedures
Questions about vision and general health
Dark adapted fundus perimetry: Participants sit in the dark for 40 minutes. Then they sit at a machine that shines lights in the eyes.
Dark adaption testing: Participants sit in the dark for 45 minutes. The pupils are dilated. They push a button when they see light in a machine for up to 1 hour.
Participants will have annual visits for up to 5 years to repeat the tests in the first visit. Participant data may be shared for other research.
|Condition or disease|
|Age- Related Macular Degeneration|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||75 participants|
|Official Title:||AMD Ryan Initiative Study (ARIS)|
|Actual Study Start Date :||February 12, 2018|
|Estimated Primary Completion Date :||December 31, 2025|
|Estimated Study Completion Date :||December 31, 2025|
Late age-related macular degeneration (AMD)
early reticular pseudodrusen (RPD)
- Enhancing the understanding of the natural history of early AMD and RPD. [ Time Frame: Ongoing ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03092492
|Contact: Angel H Garced, R.N.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 email@example.com|
|Principal Investigator:||Emily Y Chew, M.D.||National Eye Institute (NEI)|